DE10254336A1 - Carbonsäureamide - Google Patents

Carbonsäureamide Download PDF

Info

Publication number
DE10254336A1
DE10254336A1 DE10254336A DE10254336A DE10254336A1 DE 10254336 A1 DE10254336 A1 DE 10254336A1 DE 10254336 A DE10254336 A DE 10254336A DE 10254336 A DE10254336 A DE 10254336A DE 10254336 A1 DE10254336 A1 DE 10254336A1
Authority
DE
Germany
Prior art keywords
phenyl
amino
carbonyl
acid amide
thiophene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10254336A
Other languages
German (de)
English (en)
Inventor
Dieter Dr. Dorsch
Bertram Dr. Cezanne
Werner Dr. Mederski
Christos Dr. Tsaklakidis
Hanns Dr. Wurziger
Johannes Dr. Gleitz
Christoph Dr. Van Amsterdam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Priority to DE10254336A priority Critical patent/DE10254336A1/de
Priority to ES03776875T priority patent/ES2320876T3/es
Priority to DE50311133T priority patent/DE50311133D1/de
Priority to AU2003286145A priority patent/AU2003286145B2/en
Priority to PCT/EP2003/012080 priority patent/WO2004046138A1/de
Priority to US10/535,246 priority patent/US7579346B2/en
Priority to AT03776875T priority patent/ATE421515T1/de
Priority to CA2506716A priority patent/CA2506716C/en
Priority to EP03776875A priority patent/EP1562939B1/de
Priority to JP2004552505A priority patent/JP4732757B2/ja
Priority to ARP030104308A priority patent/AR042115A1/es
Publication of DE10254336A1 publication Critical patent/DE10254336A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE10254336A 2002-11-21 2002-11-21 Carbonsäureamide Withdrawn DE10254336A1 (de)

Priority Applications (11)

Application Number Priority Date Filing Date Title
DE10254336A DE10254336A1 (de) 2002-11-21 2002-11-21 Carbonsäureamide
ES03776875T ES2320876T3 (es) 2002-11-21 2003-10-30 Carboxamidas.
DE50311133T DE50311133D1 (en) 2002-11-21 2003-10-30 Carbonsäureamide
AU2003286145A AU2003286145B2 (en) 2002-11-21 2003-10-30 Carboxamides
PCT/EP2003/012080 WO2004046138A1 (de) 2002-11-21 2003-10-30 Carbonsäureamide
US10/535,246 US7579346B2 (en) 2002-11-21 2003-10-30 Carboxamides
AT03776875T ATE421515T1 (de) 2002-11-21 2003-10-30 Carbonsäureamide
CA2506716A CA2506716C (en) 2002-11-21 2003-10-30 Carboxamides
EP03776875A EP1562939B1 (de) 2002-11-21 2003-10-30 Carbonsäureamide
JP2004552505A JP4732757B2 (ja) 2002-11-21 2003-10-30 カルボキサミド
ARP030104308A AR042115A1 (es) 2002-11-21 2003-11-21 Amidas de acido carboxilico

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10254336A DE10254336A1 (de) 2002-11-21 2002-11-21 Carbonsäureamide

Publications (1)

Publication Number Publication Date
DE10254336A1 true DE10254336A1 (de) 2004-06-03

Family

ID=32240241

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10254336A Withdrawn DE10254336A1 (de) 2002-11-21 2002-11-21 Carbonsäureamide
DE50311133T Expired - Lifetime DE50311133D1 (en) 2002-11-21 2003-10-30 Carbonsäureamide

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE50311133T Expired - Lifetime DE50311133D1 (en) 2002-11-21 2003-10-30 Carbonsäureamide

Country Status (10)

Country Link
US (1) US7579346B2 (https=)
EP (1) EP1562939B1 (https=)
JP (1) JP4732757B2 (https=)
AR (1) AR042115A1 (https=)
AT (1) ATE421515T1 (https=)
AU (1) AU2003286145B2 (https=)
CA (1) CA2506716C (https=)
DE (2) DE10254336A1 (https=)
ES (1) ES2320876T3 (https=)
WO (1) WO2004046138A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1571154A1 (en) * 2004-03-03 2005-09-07 Aventis Pharma Deutschland GmbH Beta-aminoacid-derivatives as factor Xa inhibitors
CA2565186A1 (en) * 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Substituted thiophen-carboxylic acid amides, the production and the use thereof in the form of a drug
KR20070012552A (ko) 2004-05-13 2007-01-25 베링거 인겔하임 인터내셔날 게엠베하 신규한 치환된 티오펜카복스아미드, 이의 제조방법 및약제로서의 이의 용도
WO2005111013A1 (de) * 2004-05-13 2005-11-24 Boehringer Ingelheim International Gmbh Substituierte thiophen-2-carbonsäureamide, deren herstellung und deren verwendung als arzneimittel
DE102004047840A1 (de) 2004-09-29 2006-03-30 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue substituierte Thiophencarbonsäureamide, deren Herstellung und deren Verwendung als Arzneimittel
CN101094835B (zh) * 2004-11-03 2011-07-27 弗·哈夫曼-拉罗切有限公司 二酰胺衍生物
EP1724269A1 (en) * 2005-05-20 2006-11-22 Sanofi-Aventis Deutschland GmbH Heteroaryl-carboxylic acid (sulfamoyl alkyl) amide - derivatives as factor Xa inhibitors
PE20070171A1 (es) * 2005-06-30 2007-03-08 Boehringer Ingelheim Int GLICINAMIDAS SUSTITUIDAS CON EFECTO ANTITROMBOTICO E INHIBIDOR DEL FACTOR Xa
AR057976A1 (es) * 2005-08-29 2008-01-09 Boehringer Ingelheim Int Biarilos sustituidos y su uso como medicamentos.
AU2010362639B2 (en) * 2010-10-18 2016-10-27 Apotex Pharmachem Inc. Processes for the preparation of Rivaroxaban and intermediates thereof
WO2013031930A1 (ja) * 2011-08-31 2013-03-07 味の素株式会社 イミン誘導体
CN105294669B (zh) * 2014-10-24 2019-01-22 山东凯森制药有限公司 一种第十因子抑制剂及其制备方法和应用
BR112021010453A2 (pt) * 2018-12-19 2021-08-24 Leo Pharma A/S Composto, e, composição farmacêutica
EP4015501A1 (en) * 2020-12-16 2022-06-22 Consejo Superior de Investigaciones Científicas (CSIC) N-benzyl-alpha-aminoamides as anaphase-promoting complex/cyclosome (apc/c) inhibitors

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2123246C2 (de) * 1971-05-11 1982-11-25 Basf Ag, 6700 Ludwigshafen 6-[p-(β-Phenyläthylaminoacetylamino)-phenyl]-4,5-dihydropyridazon-(3)
ES2186811T3 (es) * 1995-12-29 2003-05-16 Boehringer Ingelheim Pharma Derivados de feniltiazol con propiedades anti-virus herpes.
WO2000029399A1 (en) * 1998-11-12 2000-05-25 Boehringer Ingelheim (Canada) Ltd. Antiherpes compounds
EP1185509A2 (en) * 1999-05-24 2002-03-13 Cor Therapeutics, Inc. INHIBITORS OF FACTOR Xa
US6906063B2 (en) * 2000-02-04 2005-06-14 Portola Pharmaceuticals, Inc. Platelet ADP receptor inhibitors
DE10010425A1 (de) * 2000-03-03 2001-09-06 Bayer Ag Substituierte 5-Methyldihydropyridazinone und ihre Verwendung
DE60140748D1 (de) * 2000-06-30 2010-01-21 Dainippon Sumitomo Pharma Co Thiazol-derivate zur verwendung als entzündungshemmende mittel
DE10035144A1 (de) 2000-07-19 2002-01-31 Merck Patent Gmbh Cyclische Aminosäurederivate
DE10063008A1 (de) * 2000-12-16 2002-06-20 Merck Patent Gmbh Carbonsäureamidderivate
DE10102322A1 (de) * 2001-01-19 2002-07-25 Merck Patent Gmbh Phenylderivate

Also Published As

Publication number Publication date
CA2506716A1 (en) 2004-06-03
EP1562939B1 (de) 2009-01-21
ES2320876T3 (es) 2009-05-29
AR042115A1 (es) 2005-06-08
JP4732757B2 (ja) 2011-07-27
AU2003286145B2 (en) 2009-11-12
CA2506716C (en) 2012-09-04
WO2004046138A1 (de) 2004-06-03
US20060052376A1 (en) 2006-03-09
US7579346B2 (en) 2009-08-25
JP2006512321A (ja) 2006-04-13
ATE421515T1 (de) 2009-02-15
AU2003286145A1 (en) 2004-06-15
DE50311133D1 (en) 2009-03-12
EP1562939A1 (de) 2005-08-17

Similar Documents

Publication Publication Date Title
EP1633346B1 (de) Pyrrolidin-1,2-dicarbonsäure-1-¬(4-ethinyl-phenyl)-amid|-2-¬(phenyl)-amid| derivate als inhibitoren der koagulationsfaktoren xa und viia zur behandlung von thrombosen
EP1720844B1 (de) Pyrrolidin-1,2-dicarbonsäure-1-(phenylamid)-2-(4-(3-oxo-morpholin-4-yl)-phenylamid) derivate und verwandte verbindungen als inhibitoren des koagulationsfaktors xa zur behandlung von thromboembolischen erkrankungen
EP1341755A1 (de) Carbonsäureamidderivate und ihre verwendung in der behandlung von thromboembolischen erkrankungen und tumoren
DE10329457A1 (de) Ethinylprolinderivate
EP1558247A1 (de) Benzimidazolderivate
DE10112768A1 (de) Phenylderivate 3
EP1562939B1 (de) Carbonsäureamide
DE10229070A1 (de) Phenylderivate 5
DE10315377A1 (de) Carbonylverbindungen
DE10214832A1 (de) Phenylderivate 4
EP1414456B1 (de) Phenylderivate als faktor xa inhibitoren
DE10155075A1 (de) Cyclische Sulfonamide
DE10358539A1 (de) Carbonsäureamidderivate
DE10302500A1 (de) Carbonsäureamidderivate
WO2002074735A2 (de) Biurethanderivate
EP1499591A1 (de) Carbonsäureamide als inhibitoren des koagulationsfaktors xa
EP1549304A1 (de) Heterozyklische amide und ihre verwendung in der behandlung von thromboembolischen erkrankungen und tumoren
EP1633745B1 (de) Aroylsemicarbazidderivate gegen thromboembolische erkrankungen
DE10218974A1 (de) Carnonsäureamide
DE10236868A1 (de) Carbonsäureamide
DE10327428A1 (de) Ethinylprolinderivate
DE10329295A1 (de) Carbonylverbindungen

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee